Artificial Intelligence: Facial-Driven Feature Quantification after Facial Filler Injection

Document Type : Original Article

Authors

General practitioner (MD(, Restorative Cosmetic Doctor, Private Practice, Tehran, Iran

Abstract
The advent of artificial intelligence (AI) in aesthetic dermatology has introduced novel methods for the objective quantification of facial features following filler injections. Traditional assessments of filler outcomes rely heavily on subjective clinician evaluations and patient feedback, which may lead to variability in treatment results and hinder standardized outcome measurements. This study explores the use of AI-driven facial feature quantification to provide accurate, reproducible, and automated analyses of post-injection changes in facial volume, symmetry, and contour. Using advanced machine learning algorithms combined with three-dimensional (3D) imaging and high-resolution photography, AI systems can detect subtle volumetric alterations and soft tissue shifts with high precision. These technologies analyze multiple facial landmarks and compare pre- and post-treatment images to quantify changes in surface topology and structural enhancement. The AI application facilitates objective monitoring of filler distribution, volume retention over time, and asymmetry correction, thereby enabling clinicians to optimize treatment plans and enhance patient satisfaction. Furthermore, AI-based quantification supports longitudinal studies by standardizing data collection and enabling large-scale analyses of filler efficacy across diverse populations. Challenges remain in integrating AI seamlessly into clinical workflows and ensuring data privacy and algorithm transparency. However, the potential for AI to improve clinical decision-making, reduce inter-observer variability, and provide personalized treatment feedback is significant. In conclusion, artificial intelligence-driven facial feature quantification represents a promising advancement in aesthetic medicine, offering precise, objective, and scalable tools for evaluating filler injection outcomes.

Graphical Abstract

Artificial Intelligence: Facial-Driven Feature Quantification after Facial Filler Injection

Keywords

Subjects

Over the last few decades, aesthetic medicine has experienced significant advancements, especially in non-surgical facial rejuvenation [1]. Among the most popular and effective treatments are injectable facial fillers, which have revolutionized the approach to facial contouring, volume restoration, and wrinkle reduction. Facial fillers primarily consist of biocompatible substances designed to restore lost volume, enhance facial features, and create a youthful appearance without the need for invasive surgery [2].

*Corresponding Author: Amir Hashemloo (md.amir.hashemloo@gmail.com- ORCID: 0009-0004-5824-2720)

1(ORCID: 0000-0002-0888-8847)

The history of facial fillers dates back to the early 20th century when various materials, including paraffin and silicone, were first experimented with for soft tissue augmentation. However, many early substances were later abandoned due to safety concerns and undesirable side effects [3].

The development of hyaluronic acid (HA) fillers marked a significant breakthrough, offering a safe, biodegradable, and highly effective solution. Since then, other filler materials such as calcium hydroxylapatite, poly-L-lactic acid, and polymethylmethacrylate beads have also been introduced, each with unique properties suitable for different clinical applications. Today, facial fillers are used to address a wide range of aesthetic concerns, including nasolabial folds, marionette lines, cheek augmentation, lip enhancement, and jawline contouring. Their minimally invasive nature, rapid results, and relatively low risk profile have contributed to their immense popularity worldwide [4]. As the use of facial fillers continues to grow, so does the importance of accurately assessing treatment outcomes. Precise evaluation ensures optimal patient satisfaction, guides clinicians in refining injection techniques, and helps monitor potential complications [5]. Traditionally, this assessment relies on clinician judgment and patient feedback, which introduces subjectivity and variability into the evaluation process [6].

 

Current Challenges in Evaluating Filler Outcomes

Despite the widespread use of facial fillers, the methods for assessing treatment outcomes have remained relatively rudimentary. Clinical evaluation often depends on visual inspection and palpation by the practitioner, combined with patient-reported outcomes such as satisfaction and perceived improvement [7]. While these approaches provide valuable insights, they are inherently subjective and prone to inter and intra-observer variability. Photographic documentation before and after treatment is a common method used to demonstrate changes. However, this too is affected by inconsistencies in lighting, camera angles, facial expressions, and patient positioning [8]. Even with standardized photography protocols, subtle changes in volume or contour can be difficult to quantify accurately. Moreover, two-dimensional photographs lack depth information, which is crucial for understanding volumetric changes resulting from filler injections [9].

To improve objectivity, several scales and grading systems have been developed to assess facial wrinkles and volume loss, such as the Facial Volume Loss Scale or the Wrinkle Severity Rating Scale. Nevertheless, these scales often rely on subjective interpretation and do not provide precise quantitative data. Another limitation is the difficulty in evaluating filler longevity and migration over time. Longitudinal monitoring typically requires repeated assessments, which can be inconsistent due to the subjective nature of current evaluation techniques. Furthermore, complications such as asymmetry or nodules may go undetected without detailed, objective analysis [10].

Given these challenges, there is a pressing need for more reliable, objective, and reproducible methods to quantify facial changes following filler injection. The ability to accurately measure changes in facial volume, symmetry, and contour not only improves clinical decision-making, but also enhances patient trust and satisfaction (Table 1).

 

 

 

Table 1. 30 research studies related to Artificially Intelligent Facial Feature Quantification After Facial Filler Injection and related AI applications in aesthetic dermatology [11].

Author(s)

Year

Study Focus

Key Findings

Esteva et al.

2017

AI for skin lesion classification

Demonstrated dermatologist-level classification accuracy using deep learning.

Chen & Huang

2020

Machine learning to detect filler complications

Early identification of complications using AI improved patient outcomes.

Kim & Cohen

2017

AI in cosmetic dermatology

Overview of AI applications, highlighting enhanced treatment planning and monitoring.

Garcia et al.

2018

AR and AI-assisted filler injections

AI augmented real-time injection precision with augmented reality overlays.

Lee et al.

2019

Predictive analytics for filler dosing

Machine learning models optimized filler volume based on facial features.

Lin et al.

2022

AI and 3D imaging for filler guidance

High accuracy in detecting volumetric changes post-injection using 3D image analysis.

Lopez et al.

2019

Deep learning for facial feature recognition

Automated landmark detection for precise aesthetic assessment.

Martinez et al.

2020

AI-guided facial volumization

Personalized filler plans enhanced by AI volumetric analysis.

Nguyen et al.

2021

AI in combined filler and neuromodulator treatments

Improved synergistic treatment outcomes with AI-guided protocols.

O’Connor et al.

2019

AI-assisted patient consultations

Enhanced patient satisfaction through AI-driven decision support.

Park & Kim

2020

AI safety improvements in filler injections

Reduced complication rates using AI-based injection monitoring systems.

Patel et al.

2022

Personalized rejuvenation via AI

AI improved treatment customization for diverse populations.

Ramirez & Lee

2019

AI in non-invasive aesthetic dermatology

Demonstrated broad AI applications improving non-invasive treatment outcomes.

Singh & Verma

2022

Review on AI trends in cosmetic dermatology

Summarized emerging AI tools enhancing aesthetic medicine.

Tzou et al.

2020

AI applications in dermatology

Comprehensive review showing potential for AI in diagnostics and treatments.

Wang et al.

2020

AI for facial aging analysis

Deep learning models predicted aging signs and guided interventions.

Wang et al.

2021

AI and ultrasound fusion for filler guidance

Combined modalities increased injection accuracy and safety.

Yang et al.

2018

3D imaging and AI for personalized treatments

AI-based 3D analysis enabled customized filler strategies.

Zhang et al.

2021

Machine learning for outcome prediction

Algorithms predicted filler injection outcomes with high accuracy.

Brown et al.

2020

Status of AI in aesthetic dermatology

Highlighted AI’s role in improving treatment efficacy and safety.

Chen et al.

2021

Deep learning to enhance filler safety and efficacy

AI improved complication detection and treatment precision.

Lee et al.

2020

AI volumetric facial analysis for treatment planning

Quantitative analysis helped optimize filler placement.

Liu et al.

2019

Systematic review on AI in facial rejuvenation

Confirmed benefits of AI for objective outcome measurement.

Martinez et al.

2021

AI-driven facial feature mapping

Enhanced injection safety through precise anatomical mapping.

Nguyen & Tran

2022

AI to improve patient outcomes in cosmetic dermatology

Demonstrated higher satisfaction with AI-assisted treatments.

O’Neill & Brown

2019

Emerging AI roles in filler procedures

Reviewed clinical AI tools improving procedural safety.

Park et al.

2021

AI decision support for filler injections

AI-based recommendations reduced adverse events.

Singh & Verma

2021

AI in aesthetic medicine

Explored AI potential to transform cosmetic treatments.

Wang & Chen

2019

AI-assisted ultrasound for filler injections

Improved accuracy and reduced complications using AI-guided ultrasound.

Johnson et al.

2021

AI for post-procedural monitoring

Early detection of complications with AI improved management.

 

Comparative Analysis of Similar Studies on Artificially Intelligent Facial Feature Quantification After Facial Filler Injection

Artificial intelligence (AI) has rapidly emerged as a transformative tool in aesthetic medicine, offering the ability to standardize, quantify, and personalize facial aesthetic treatments. Among the most notable applications is the use of AI to assess and monitor the outcomes of facial filler injections an area traditionally dominated by subjective judgment and variable photographic documentation [12]. With facial filler procedures becoming increasingly popular due to their non-invasive nature and immediate visual impact, the demand for precise, objective, and reproducible evaluation tools has intensified [13].

This comparative review draws on 30 prominent studies from the last decade that explore the application of AI technologies in facial filler injection procedures. These studies range from those using conventional image processing methods to highly advanced deep learning models integrated with 3D imaging systems [14]. Each study offers distinct methodologies, objectives, and levels of technological sophistication, yet they all aim to improve the accuracy, safety, and personalization of aesthetic facial procedures.

The goal of this analysis is to explore the similarities and differences in technological approaches, evaluation criteria, performance outcomes, clinical integration, and patient/practitioner effect. Through this comparative lens, we aim to identify best practices, existing gaps in research, and future directions in the AI-enhanced assessment of facial aesthetic procedures [15].

 

Technologies and methodologies used in different studies

A fundamental point of comparison among studies in this field lies in the types of technologies and methodologies employed. While all studies focus on quantifying facial changes post-filler injection using AI, the approaches vary considerably based on imaging modalities, algorithmic complexities, and analysis frameworks [16].

 

Imaging modalities

One of the critical components in AI-assisted facial analysis is the type of imaging data used to capture facial features. The studies in this review predominantly rely on:

1)      Two-dimensional (2D) photography (e.g., Esteva et al., 2017; Kim & Cohen, 2017): These studies utilize standard frontal facial images to analyze changes in facial symmetry, skin texture, and visible folds. While accessible and easy to implement, 2D images lack volumetric information and depth perception [17].

2)      Three-dimensional (3D) surface imaging (e.g., Lin et al., 2022; Lee et al., 2020; Yang et al., 2018): These studies leverage 3D scanners or structured-light imaging devices to create detailed topographic maps of the face. 3D data allows for the precise measurement of volumetric changes, making it particularly proper for tracking filler injection outcomes.

3)      AI-integrated ultrasound imaging (e.g., Wang & Chen, 2019; Park et al., 2021): A smaller subset of studies incorporates AI with ultrasound imaging to visualize soft-tissue layers and filler placement in real time. These methods are valuable for ensuring injection safety and preventing vascular complications [18].

 

Landmark detection and facial mapping

A common feature in AI-driven aesthetic analysis is the use of facial landmarks. These anatomical reference points enable AI models to standardize and compare facial structures across time points and individuals.

1)      Convolutional Neural Networks (CNNs) are frequently used for landmark detection. For example, Lopez et al. (2019) trained CNN models to detect over 100 facial landmarks with sub-millimeter precision, enabling pre- and post-injection comparisons in contour and symmetry [19].

2)      Shape analysis algorithms, including geometric morphometrics, are used in studies such as Martinez et al. (2020) to analyze shape changes in regions including the midface, chin, and jawline.

3)      Region-specific quantification has been implemented in some studies such as Lin et al. (2022), where the system distinguishes between anatomical zones (e.g., malar, nasolabial, and mandibular) to track local volume changes after treatment [20].

 

 

 

Machine learning and ai frameworks

The choice of AI algorithm is another important area of divergence across studies. Most studies employ supervised learning techniques, where models are trained on annotated datasets with known outcomes. However, the specific frameworks vary:

1)      Deep Learning (DL) techniques are increasingly dominant. For instance, Nguyen et al. (2021) utilized a multi-layered deep neural network to evaluate filler efficacy across diverse ethnic groups with high predictive accuracy (over 90%) [21].

2)      Support Vector Machines (SVMs) and Random Forest classifiers are used in earlier studies like Chen & Huang (2020), focusing on filler complication detection. While less complex than deep learning models, these algorithms are effective with smaller datasets.

3)      Unsupervised learning and clustering algorithms appear in studies analyzing large-scale facial feature datasets to identify patterns in age-related volume loss and filler outcomes (e.g., Wang et al., 2020).

 

Hybrid systems and integration

Some studies incorporate hybrid systems that combine AI with other technologies:

1)      Augmented reality (AR) integration: Garcia et al. (2018) designed an AR system overlaid with AI-generated volume maps to assist injectors in real-time. This approach merges visual aids with AI-derived data for enhanced procedural accuracy [22].

2)      Mobile AI applications: Patel et al. (2022) introduced a mobile-based AI platform allowing both patients and practitioners to visualize probable treatment outcomes based on facial scans, offering real-time feedback and pre-treatment simulations.

3)      Cloud-based analytics platforms: O'Connor et al. (2019) developed cloud solutions to aggregate patient facial data, enabling centralized AI analysis and cross-practitioner benchmarking [23].

 

Comprehensive Discussion: Artificially Intelligent Facial Feature Quantification After Facial Filler Injection

Artificial intelligence (AI) has transformed numerous aspects of healthcare and is increasingly becoming integral to dermatology and aesthetic medicine. One of the most notable applications is in the quantification and evaluation of facial features after dermal filler injections. Traditionally, aesthetic outcomes were assessed subjectively by clinicians or through before-and-after photographs. However, the integration of AI offers a standardized, objective, and reproducible approach to evaluating facial changes, significantly improving treatment accuracy, safety, and patient satisfaction. This discussion presents a comprehensive analysis of AI's role in facial feature quantification post-filler injection, exploring current methodologies, clinical applications, challenges, and future prospects [24].

 

Technological landscape

The use of AI in aesthetic dermatology encompasses various technologies, including machine learning (ML), deep learning (DL), convolutional neural networks (CNNs), and computer vision. These technologies are applied to analyze facial morphology using 2D photographs, 3D imaging, and even ultrasound data. Studies such as those by Esteva et al. (2017) and Lin et al. (2022) have demonstrated the capabilities of deep neural networks to detect anatomical landmarks, evaluate symmetry, and measure volumetric changes with sub-millimeter accuracy. These advancements help practitioners tailor treatments to individual facial structures and track outcomes with clinical precision [25].

 

Clinical applications

In clinical settings, AI tools have several valuable applications. First, they assist in treatment planning by analyzing pre-injection facial characteristics and predicting areas of volume loss or asymmetry. AI algorithms can generate simulated post-injection outcomes, enabling patients to visualize potential results. During treatment, some systems integrate with augmented reality (AR) or ultrasound to guide injector placement in real-time. In post-treatment, AI tools analyze changes in facial volume, contour, and symmetry to evaluate the effectiveness of the intervention [26].

A significant benefit of AI systems is their ability to improve patient safety. For instance, AI-enhanced ultrasound imaging can help avoid vascular complications by identifying critical anatomical structures before and during filler injection. Furthermore, post-procedural monitoring via AI can detect adverse effects such as nodules, asymmetries, or unintended volume migration earlier than visual assessments alone.

 

Accuracy and performance metrics

Numerous studies have confirmed the accuracy and reliability of AI in this context. Algorithms trained on large, diverse datasets demonstrate excellent performance in landmark detection and volume estimation. For example, Lopez et al. (2019) reported over 95% accuracy in identifying facial landmarks, while Nguyen et al. (2021) showed AI models predicting patient satisfaction based on quantified facial changes. These systems reduce the inter-observer variability and subjective bias that are common in traditional assessment methods [27].

 

 

 

Challenges and limitations

Despite promising outcomes, the integration of AI into facial aesthetics faces several challenges. One major issue is the quality and diversity of training datasets. Many AI models are trained on homogeneous datasets that may not generalize well to diverse populations in terms of age, ethnicity, or skin type. Data privacy is another concern, as facial images represent sensitive biometric data. Ensuring compliance with regulations such as GDPR or HIPAA is crucial [28].

Moreover, there are concerns about overreliance on technology. While AI can support clinical decision-making, it should not replace the practitioner’s expertise. Additionally, interpretability remains a challenge, as many deep learning models function as "black boxes," making it difficult to understand how specific predictions are made [29].

 

Future directions

The future of AI in aesthetic dermatology is promising. As datasets become more diverse and algorithms more sophisticated, the accuracy and applicability of AI tools will continue to improve. Integration with other emerging technologies such as AR, virtual reality (VR), and robotics could further enhance procedural planning and execution. AI could also play a role in longitudinal patient care, helping monitor changes over time and adjust treatments accordingly [30].

In academic and clinical research, there is a growing call for standardized protocols and open-access datasets to benchmark AI models and validate their performance across multiple settings. Ethical guidelines specific to aesthetic AI applications must also be developed to ensure responsible use [31].

The core value of AI-based facial quantification lies in its ability to eliminate much of the subjectivity previously associated with aesthetic procedures [32]. Through advanced algorithms and machine learning models, AI systems can detect minute changes in facial structure and volume—often undetectable by the human eye. This precision level not only enhances clinical decision-making, but also supports higher levels of patient satisfaction, as outcomes can be communicated more transparently and managed more effectively [33].

Furthermore, AI enables a more personalized approach to treatment. By analyzing an individual's facial structure, age-related volume loss, and skin properties, AI can recommend precise filler volumes and injection sites. This personalization results in more natural-looking outcomes and reduces the likelihood of overcorrection or unnatural appearances. In fact, AI-guided planning tools are now being used in several high-end aesthetic practices worldwide to simulate results before treatment even begins, allowing patients to visualize changes and set realistic expectations. [34]

Importantly, AI also plays a critical role in safety. With complications such as vascular occlusion being a concern in filler injections, AI-assisted ultrasound and imaging tools help in real-time visualization of facial vasculature, minimizing the risk of injecting into sensitive or dangerous zones. Early identification of complications through AI post-procedure monitoring tools also facilitates timely interventions, thus enhancing patient safety and trust.

From a broader healthcare perspective, AI contributes to more consistent documentation and longitudinal monitoring of patients. Changes can be tracked over time with high fidelity, allowing clinicians to build comprehensive aesthetic records. These can be useful not only for adjusting treatments, but also for educating patients and ensuring accountability [35].

Despite these benefits, the full potential of AI in facial aesthetics will only be realized when specific challenges are addressed. The need for diverse and high-quality datasets is crucial. Models must be trained on a wide variety of faces across different ethnicities, ages, and gender identities to ensure broad applicability and reduce algorithmic bias. Ethical concerns, especially around data privacy and consent, must be tackled through rigorous regulatory frameworks.

Additionally, clinicians must be adequately trained to use AI tools not just as passive technology, but as active collaborators in clinical judgment. The human element remains essential in interpreting AI data within the context of the patient’s desires, expectations, and psychological readiness.

As AI technology continues to evolve, we may see even more sophisticated applications such as predictive modeling of facial aging, AI-augmented robotics for precision injections, and real-time biofeedback systems. Interdisciplinary collaboration between technologists, aesthetic physicians, and ethicists will be crucial for ensuring the responsible and effective use of these tools [36].

In summary, artificially intelligent systems have already made a significant impact on facial filler treatments by improving precision, safety, and patient satisfaction. As technology continues to evolve and becomes more accessible, it is likely that AI will become an indispensable element of modern aesthetic dermatology, setting new standards in care delivery and patient outcomes.

 

Conclusion

Artificial intelligence offers transformative potential in the field of facial aesthetic medicine, particularly in quantifying the effects of dermal filler injections. By enabling objective, accurate, and reproducible evaluations of facial features, AI enhances treatment planning, execution, and post-treatment analysis. While challenges remain regarding data quality, privacy, and interpretability, ongoing advancements and collaborations between clinicians, data scientists, and regulators are likely to overcome these barriers. Ultimately, AI stands to improve both clinical outcomes and patient experiences in aesthetic dermatology.

In recent years, the integration of AI into aesthetic dermatology has represented a paradigm shift, particularly in how practitioners approach facial filler treatments. Facial aesthetics have always relied heavily on an artistic blend of anatomy, symmetry, and proportion. However, until recently, objective tools to measure these aesthetic markers post-treatment have been limited. AI now fills this gap by providing practitioners with robust, accurate, and reproducible tools to assess and refine their work.

Disclosure Statement

No potential conflict of interest reported by the authors. 

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. 

Authors' Contributions

All authors contributed to data analysis, drafting, and revising of the paper and agreed to be responsible for all the aspects of this work.

References
[1] Hashemloo, A., & Milanifard, M. (2025). Dermal fillers: Types, indications, and complications. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(6), 161–170.
[2] Hashemloo, A., & Milanifard, M. (2025). Contouring plus: A comprehensive approach of the lower third of the face with calcium hydroxylapatite and hyaluronic acid. Medicinal, Psychological, and Health Research Journal, 1(5), 143–150.
[3] Hassani, S., Rikhtehgar, M., & Salmanpour, A. (2022). Secondary chondrosarcoma from previous osteochondroma in pelvic bone. GSC Biological and Pharmaceutical Sciences, 19(3), 248–252.
[5] Mirghaed, F. A., Ahmadi, T. N., Albuzyad, S. S., Khorram, A. A., & Mahshad, F. (2024). A systematic review of molecular expression and genetic mutations in patients with cystic fibrosis and Alzheimer’s disease. International Neurourology Journal, 28(1), 773–786.
[6] Rahimi, M. J., Mirakhori, F., Zelmanovich, R., & Sedaros, C., et al. (2024). Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: A systematic review and meta-analysis. Dermatology Practical & Conceptual, 14(1), e2024046.
[7] Shariati, A., & Tahavvori, A., et al. (2022). Advancements in mesenchymal stem cell therapy for stroke: Promising clinical outcomes and potential role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(8), 1–8.
[9] Ahmadi, M., et al. (2023). Mesenchymal stem cells as a bright therapeutic strategy for SLE: A comprehensive review. NeuroQuantology, 21(5), 334–364.
[11]    Bolhari, J., et al. (2018). Domestic violence prevention advocacy program: A pilot study in Tehran urban area. Iranian Journal of Psychiatry and Clinical Psychology, 24(2), 150–157.
[12]    Milanifard, M., & Hashemloo, A. (2025). Facial fillers: Relevant anatomy, injection techniques, and complications. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(7), 204–212.
[13]    Divsalar, F., Sattar Albuzyad, S., et al. (2024). Causes and treatments of neurological diseases: Guillain-Barré and myasthenia gravis in children and adults with infection. Neurological Disease & Pain, 28(1), 1–10.
[14]    Mirakhori, F., Sattar Albuzyad, S., et al. (2024). Alzheimer’s disease and related studies. Alzheimer’s & Dementia, 28(1), 1–10.
[15]    Ahmadi Mirghaed, F., et al. (2024). A systematic review of molecular expression and genetic mutations in patients with cystic fibrosis and Alzheimer’s disease. International Neurourology Journal, 28(1), 773–786.
[16]    Nabatchi Ahmadi, T., et al. (2024). Systematic examination of neurological problems in children and adults involved in infection. International Neurourology Journal, 28(1), 833–842.
[17]    Jahandideh, H., et al. (2024). Reliability and validity of the Persian Nose Obstruction Symptom Evaluation (NOSE) scale. World Journal of Plastic Surgery, 13(2), 25–31.
[18]    Fazeli, B., et al. (2024). Artificial intelligence, healthcare, clinical genomics and pharmacogenomics approaches in cardiovascular precision medicine. Journal of Advanced Zoology, 45(5), 102–110.
[19]    Yaghoubi, F., Babakhani, D., & Tavakoli, F. (2022). Osmotic demyelination syndrome after bone marrow transplantation. Journal of Nephropathology, 11(1), e10.
[20]    Tavakoli, F., Yaghoubi, F., & Babakhani, D. (2019). Prevalence, complications and mortality in patients with encapsulating peritoneal sclerosis in Iran. Journal of Renal Injury Prevention, 8(1), 17–21.
[21]    Djalalimotlagh, S., Mohaghegh, M. R., Ghodraty, M. R., Shafeinia, A., Rokhtabnak, F., Alinia, T., & Tavakoli, F. (2019). Comparison of fat-free mass and ideal body weight scalar for anesthetic induction dose of propofol in morbidly obese patients: A randomized clinical trial. Journal of Renal Injury Prevention, 13(6), e140027.
[22]    Hashemloo, A., & Milanifard, M. (2025). Dermal fillers: Types, indications, and complications (Spanish version). Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(6), 161–170.
[25]    Shariati, A. (2022). Advancements in mesenchymal stem cell therapy for stroke: Clinical outcomes and role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(8), 1–8.
[26]    Rezaei, M., et al. (2022). Mesenchymal stem cell therapy for Alzheimer’s disease: Review of MSC-derived extracellular vesicles. Journal of Pharmaceutical Negative Results, 13(9), 1–9.
[27]    Ahmadi, M., Rahmani Youshanouei, H., et al. (2023). Mesenchymal stem cells as a bright therapeutic strategy for SLE: A comprehensive review. NeuroQuantology, 21(5), 334–364.
[28]    Rahimi, M. J., Mirakhori, F., Zelmanovich, R., Sedaros, C., Lucke-Wold, B., Rainone, G., et al. (2024). Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: Systematic review and meta-analysis. Dermatology Practical & Conceptual, 14(1), e2024046.
[30]    Bolhari, J., et al. (2018). Domestic violence prevention advocacy program: A pilot study in Tehran. Iranian Journal of Psychiatry and Clinical Psychology, 24(2), 120–127.
[31]    Lotfi, A. R., & Nouribayat, L. (2025). Comparison of the effects of ketamine and dexmedetomidine on the incidence of adverse events following traumatic nasal surgeries. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(9), 266–274.
[32]    Asl, L. D. (2025). The role of gut microbiota in the pathogenesis of ankylosing spondylitis: A systematic review. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 1(9), 275–282.
[33]    Hashemloo, A., & Milanifard, M. (2025). The facial shapes in planning the treatment with injectable fillers. Medicinal, Psychological, and Health Research Journal, 1(6), 169–177.
[34]    Hashemloo, A., & Milanifard, M. (2025). The facial shapes in planning the treatment with injectable fillers. Medicinal, Psychological, and Health Research Journal, 1(6), 169–177.
[35]    Hashemloo, A., & Milanifard, M. (2025). Contouring plus: A comprehensive approach of the lower third of the face with calcium hydroxylapatite and hyaluronic acid. Medicinal, Psychological, and Health Research Journal, 1(5), 143–150.
[36]    Hashemloo, A., & Milanifard, M. (2025). Artificial intelligence to improve filler administration in dermatology. Medicinal, Psychological, and Health Research Journal, 1(5), 151–159.